PG
VIVO

PEAK6 Group’s Meridian Bioscience Inc VIVO Stock Holding History

PEAK6 Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$171K Buy
+10,759
New +$160K ﹤0.01% 3438
2016
Q3 		– Sell
-8,625
Closed -$168K – 4849
2016
Q2 		$168K Buy
+8,625
New +$169K ﹤0.01% 3266
2015
Q4 		– Sell
-3,304
Closed -$56K – 5440
2015
Q3 		$56K Sell
3,304
-43,725
-93% -$799K ﹤0.01% 4616
2015
Q2 		$877K Buy
+47,029
New +$872K 0.01% 2223

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PEAK6 Group's VIVO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Meridian Bioscience Inc (VIVO) in Q2 2018: 10,759 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #3438 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in VIVO as recently as Q2 2016.

PEAK6 Group first reported a position in VIVO in Q2 2015 and has held it in 4 quarters since. The position peaked at $877K in Q2 2015. 177 funds tracked by Wall St. Rank hold VIVO as of Q2 2018.

  • PEAK6 Group held 10,759 shares of Meridian Bioscience Inc worth $171K as of Q2 2018.
  • Meridian Bioscience Inc was a new PEAK6 Group position in Q2 2018.
  • Meridian Bioscience Inc made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3438 holding.
  • PEAK6 Group first reported a position in Meridian Bioscience Inc in Q2 2015 and has held it in 4 quarters since.
  • PEAK6 Group's Meridian Bioscience Inc position peaked at $877K in Q2 2015.
  • 177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.